Skip to content

Prospective validation of a predictive model for early urinary catheter removal after HoLEP based on prostate enucleation weight - a cohort study

Prospective validation of a predictive model for early urinary catheter removal after HoLEP based on prostate enucleation weight - a cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093618
Enrollment
Unknown
Registered
2024-12-09
Start date
2024-12-09
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Small prostate group:none
Large prostate group:none

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Male, no age limit, patients with surgical indications according to the 2019 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases: 1. BPH patients with moderate to severe LUTS who have significantly affected their quality of life, especially those who have poor drug treatment outcomes or refuse to receive drug treatment. 2. When BPH is combined with the following complications: repeated urinary retention; Repeated hematuria; Repeated urinary tract infections; bladder stone; Secondary upper urinary tract hydronephrosis (with or without renal dysfunction). 3. BPH patients with inguinal hernia, severe hemorrhoids or prolapse, who are clinically judged to have difficulty achieving therapeutic effects without relieving lower urinary tract obstruction. 4. Sign the informed consent form and be willing to participate in the research.

Exclusion criteria

Exclusion criteria: 1. Patients with urethral stricture. 2. Neurogenic bladder. 3. Weak detrusor muscle. 4. History of previous prostate surgery or lower urinary tract surgery. 5. Combine patients with other serious systemic diseases. 6. Patients with coagulation dysfunction or undergoing anticoagulant therapy.

Design outcomes

Primary

MeasureTime frame
Incidence rate of urinary retention;

Secondary

MeasureTime frame
Postoperative complications;operative time;Qmax;PVR;PSA;

Countries

China

Contacts

Public ContactChun Jiang

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

jiangch@mail.sysu.edu.cn+86 135 8057 4886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026